A Study of JNJ-73763989 in Healthy Japanese Adult Participants

NCT04002752 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-73763989
DRUG: Placebo

Sponsor

Janssen Sciences Ireland UC